Skip to content

Medical emergency? What to do

Scientists fight leukaemia with 'natural killer' cells

3-RXPublished March 9, 20063 min read

Key points

  • Scientists at the University of the West of England and the Bone Marrow Transplant Unit at the Bristol Children's Hospital have just won funding for a two-year project aimed at improving the outcome of bone marrow stem-cell transplants in young leukaemia patients.
  • "Medical research is important to us all and especially to children.
  • After an initial year of successful investigations researchers at UWE have discovered that NKT-cells possess the target antigen for Campath, already known to be present on the surface of T-cells.
  • "Patients who have consented to take part in this study will have a research blood sample taken at the same as their routine blood tests before transplant and at 3, 6 and 12 months after transplant.

Scientists at the University of the West of England and the Bone Marrow Transplant Unit at the Bristol Children's Hospital have just won funding for a two-year project aimed at improving the outcome of bone marrow stem-cell transplants in young leukaemia patients.

After a stem cell transplant there is a significant risk that grafted donor white blood cells, known as T-cells, will attack the recipient and may cause a fatal complication called graft versus host disease (GvHD). In Bristol a monoclonal antibody called Campath is used to kill donor T-cells, reducing the chance of GvHD. A side effect of Campath therapy is delayed recovery of the immune system after the transplant which may be associated with leukaemic relapse.

UWE vice-chancellor Sir Howard Newby commented:

"Medical research is important to us all and especially to children. Basic scientific research cannot guarantee cures but in the longer term this important study could help children unfortunate enough to have to undergo a transplant and their families and friends. This award is evidence of the excellence of scientific research in our city."

The UWE project will monitor the patient's immune system to see how quickly it recovers following transplantation. In particular, the researchers are focussing on the role played by 'natural killer T-cells' (NKT-cells), which form a tiny but important population of white cells present in the blood of normal individuals including stem cell donors. The UWE group hypothesise that NKT-cells play a vital role killing remaining leukaemic cells in the patient's system after the transplant thus leading to a higher probability of cure.

After an initial year of successful investigations researchers at UWE have discovered that NKT-cells possess the target antigen for Campath, already known to be present on the surface of T-cells. This means that unfortunately NKT-cells are also likely to be removed by Campath treatment. To investigate this important observation further the UWE researchers have just been awarded ?97,000 additional funding by the charity CHILDREN with LEUKAEMIA.

Project leader Dr Craig Donaldson explains, "Initially, the treatment with Campath means the graft 'takes' better but unfortunately a significant proportion of transplant patients relapse over time and eventually die of leukemia. An important part of this project is to study the rate of repopulation of vital NKT-cells in patients who have received Campath treated grafts in comparison with patients who do not receive Campath treatment."

"Patients who have consented to take part in this study will have a research blood sample taken at the same as their routine blood tests before transplant and at 3, 6 and 12 months after transplant. When the stem cell donor is a family member they will also be asked whether they wish to participate by consenting to having a research blood sample being taken when they attend the transplant unit for their routine pre-transplant blood check."

The Bone Marrow Transplant unit based in the Paul O'Gorman wing of the new Bristol Children's Hospital has an international reputation for developing novel methods of improving the results of stem cell transplants in young patients with leukaemia. Laboratory studies are being carried out at the Centre for Research in Biomedicine at the University of the West of England by Barbara Rees under the supervision of Dr Craig Donaldson and Professor Jill Hows.

http://www.uwe.ac.uk

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.